Zouina Sarfraz: I will be lead guest editing a special collection titled ‘Towards Universal Cancer Care’
Zouina Sarfraz, Associate Editor at
“I am pleased to announce that I will be lead guest editing a special collection titled ‘Towards Universal Cancer Care: Addressing Global Delivery Disparity and Financial Toxicity,’ to be published in INQUIRY: The Journal of Health Care Organization, Provision, and Financing (Sage).
This collection explores the challenges and solutions in cancer care delivery and the financial toxicity associated with them across both the global North and South. This initiative provides an extensive analysis of how various health systems address cancer burdens, covering topics like epidemiological trends, comparative analyses of treatment models, and systemic contributors to financial toxicity. It also explores innovative financial strategies, patient and caregiver narratives, the role of technology in enhancing care accessibility, and the integration of patient-centered care to improve oncological outcomes.
Co-guest edited by Manmeet Ahluwalia, MD, MBA, FASCO, and Anwaar Saeed, both distinguished leaders in their respective fields:
Manmeet Ahluwalia, MD, MBA, FASCO, Fernandez Family Endowed Chair in Cancer Research, serves as the Chief Scientific Officer, Chief of Medical Oncology, and Deputy Director at Miami Cancer Institute (MCI), Baptist Health South Florida. His career highlights include transforming the Burkhardt Brain Tumor and Neuro-Oncology Center into a leading center for brain tumor trials as its head at the Cleveland Clinic. Currently, Dr. Ahluwalia leads cutting-edge research in AI-based radiomics in glioblastoma with a substantial NIH R01 grant of $3.9 million and oversees a NIH PO1 grant exceeding $10 million focused on gender-specific differences in glioblastoma. His work has notably altered neuro-oncology practices across the U.S.
Anwaar Saeed, MD, is an Associate Professor of Medicine and leads the Gastrointestinal (GI) Medical Oncology Program at the University of Pittsburgh, UPMC, and UPMC Hillman Cancer Center. As the Vice Chair of the Colorectal Cancer Committee of the NSABP Foundation, she specializes in immune modulatory approaches in gastric, esophageal, and colorectal cancers. Dr. Saeed has authored over 150 peer-reviewed publications and led more than 40 clinical trials focusing on innovative immunotherapy combinations, including the ongoing phase I/II CAMILLA multicohort study. She is also gearing up to chair a national trial under SWOG/intergroup NCI targeting advanced gastric & esophageal adenocarcinoma with a novel chemo-immunotherapy regimen.
Submissions are now open through October 12, 2024. For submission guidelines, please visit here.
For further queries, I may be reached directly. We look forward to your contributions to this important discourse in global health.”
Read further.
Source: Zouina Sarfraz/LinkedIn